PubMed · 2018 · 10 citations · 23 references
MedicineCardiologyClinical CardiologyHemostasisInterventional CardiologyAcute Coronary Syndrome InterventionAcute Coronary SyndromesCardiovascular DiseaseCoronary Artery DiseaseIschemic Heart DiseaseThrombosisCoronary Thrombus ManagementMyocardial Infarction Risk StratificationPhospholipase A2 InhibitionPhospholipase A2 PathwayThrombus CharacterizationThrombus Removal
BACKGROUND: levels in STEMI patients undergoing PPCI with HTB. METHODS AND RESULTS: levels decreased by 53.9% in the TA group (152.9 ± 58.1 ng/mL) and decreased by 31.2% in the standard PPCI group (84.2 ± 86.6 ng/mL, p < 0.001). The TA group had a significantly lower prevalence of balloon predilatation, number of stents used, total stent length and corrected thrombolysis in myocardial infarction frame count, and a higher percentage of myocardial blush grade ≥ 2 compared with the standard PPCI group (all p < 0.001). No significant difference between the groups was observed in 30 ± 2 days for major adverse cardiovascular and cerebrovascular events (p = 0.702). CONCLUSIONS: in STEMI patients undergoing PPCI with HTB.
23
2014 ESC/EACTS Guidelines on myocardial revascularization
European Heart Journal · 2014 · 4.3K citations · Full text
Medicine, Cardiology, Surgery +14
2014 ESC/EACTS Guidelines on myocardial revascularization
Philippe Kolh, Stephan Windecker, Fernándo Alfonso et al. · European Journal of Cardio-Thoracic Surgery · 2014 · 4.2K citations · Full text
Medicine, Cardiology, Surgery +14
Universal Definition of Myocardial Infarction: Clinical Insights
Luís Paiva, Rui Providência, Sérgio Barra et al. · Cardiology · 2015 · 2.5K citations